Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer
113 of 115 enrolled patients underwent timely surgery; two had surgery delayed by more than two weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.